HEALTH TIPS.: Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds: Rituximab, a drug widely used in patients with lymphoma, blunts or eliminates the antibody response to COVID-19 vaccines if it is administered before them, Stanford researchers say.

Thursday 10 February 2022

Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds: Rituximab, a drug widely used in patients with lymphoma, blunts or eliminates the antibody response to COVID-19 vaccines if it is administered before them, Stanford researchers say.

Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds: Rituximab, a drug widely used in patients with lymphoma, blunts or eliminates the antibody response to COVID-19 vaccines if it is administered before them, Stanford researchers say.

submitted by /u/shallah
[link] [comments]

from Health https://ift.tt/LXGvTz1
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)